Revvity earnings were $286.6M for the trailing 12 months ending Mar 30, 2025, with 92.6% growth year over year. The latest RVTY earnings report on Mar 30, 2025 announced Q1 2025 earnings of $42.2M, down 55.4% from last quarter. For the last reported fiscal year 2024 ending Dec 29, 2024, RVTY reported annual earnings of $270.4M, with -61% growth.
RVTY past earnings growth
How has RVTY's earnings growth performed historically?
On RVTY's earnings call on Invalid Date, Revvity (NYSE: RVTY) reported Q1 2025 earnings per share (EPS) of $0.35, up 66.67% year over year. Total RVTY earnings for the quarter were $42.24 million. In the same quarter last year, Revvity's earnings per share (EPS) was $0.21.
As of the last Revvity earnings report, Revvity is currently profitable. Revvity's net profit (also called net income) for the twelve months ending Mar 30, 2025 was $286.61 million, a 91.54% increase year over year.
What was RVTY's earnings growth in the past year?
As of Revvity's earnings date in Invalid Date, Revvity's earnings has grown 92.62% year over year. This is 88.3 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 4.33%. RVTY earnings in the past year totalled $286.61 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.